Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Spero Therapeutics (SPRO) Preferred Dividend Payments (2016 - 2017)

Spero Therapeutics (SPRO) has disclosed Preferred Dividend Payments for 2 consecutive years, with $833000.0 as the latest value for Q4 2017.

  • For the quarter ending Q4 2017, Preferred Dividend Payments fell 9.26% year-over-year to $833000.0, compared with a TTM value of $6.1 million through Dec 2017, changed N/A, and an annual FY2017 reading of $6.1 million, up 78.61% over the prior year.
  • Preferred Dividend Payments was $833000.0 for Q4 2017 at Spero Therapeutics, down from $2.1 million in the prior quarter.
  • Across five years, Preferred Dividend Payments topped out at $2.1 million in Q3 2017 and bottomed at $833000.0 in Q4 2017.